11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Experimental Medicine

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 16103409PMCID PMC2212859
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glucocorticoid regulation of the inflammatory response to injury

  2004cited by this paper
• Predictors of the incident metabolic syndrome in adults: the Insulin Resistance Atherosclerosis Study.

  2004cited by this paper
• Increased expression and activity of 11beta-HSD-1 in diabetic islets and prevention with troglitazone.

  2004cited by this paper
• Regulation of 11beta-HSD genes in human adipose tissue: influence of central obesity and weight loss.

  2004cited by this paper
• Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission.

  2003cited by this paper
• Selective inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains.

  2003cited by this paper
• Chronic Stress Accelerates Atherosclerosis in the Apolipoprotein E Deficient Mouse

  2003cited by this paper
• Body fat distribution and cortisol metabolism in healthy men: enhanced 5beta-reductase and lower cortisol/cortisone metabolite ratios in men with fatty liver.

  2003cited by this paper
• Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice.

  2003cited by this paper
• Tissue-specific Cushing's syndrome, 11beta-hydroxysteroid dehydrogenases and the redefinition of corticosteroid hormone action.

  2003cited by this paper
• Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)--a promising drug target for the treatment of metabolic syndrome.

  2003cited by this paper
• Is 11beta-hydroxysteroid dehydrogenase type 1 a therapeutic target? Effects of carbenoxolone in lean and obese Zucker rats.

  2003cited by this paper
• 11β-Hydroxysteroid dehydrogenase Type 1 as a novel therapeutic target in metabolic and neurodegenerative disease

  2003cited by this paper
• Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.

  2002cited by this paper
• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

  2002cited by this paper
• 11β-Hydroxysteroid dehydrogenase antisense affects vascular contractile response and glucocorticoid metabolism

  2002cited by this paper
• Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice

  2002cited by this paper
• Increased glucocorticoid receptor expression in human skeletal muscle cells may contribute to the pathogenesis of the metabolic syndrome.

  2002cited by this paper
• 11 beta-Hydroxysteroid dehydrogenase antisense affects vascular contractile response and glucocorticoid metabolism.

  2002cited by this paper
• Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells

  2002cited by this paper
• Expression of 11β-Hydroxysteroid Dehydrogenase Type 1 in Adipose Tissue Is Not Increased in Human Obesity

  2002cited by this paper
• Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity.

  2002cited by this paper
• Peroxisome proliferator-activated receptor-gamma ligands inhibit adipocyte 11beta -hydroxysteroid dehydrogenase type 1 expression and activity.

  2001cited by this paper
• A Transgenic Model of Visceral Obesity and the Metabolic Syndrome

  2001cited by this paper
• Lack of tissue glucocorticoid reactivation in 11β-hydroxysteroid dehydrogenase type 1 knockout mice ameliorates age-related learning impairments

  2001cited by this paper
• Tissue-specific dysregulation of cortisol metabolism in human obesity.

  2001cited by this paper
• 11 Beta-hydroxysteroid dehydrogenase type 1 is induced in human monocytes upon differentiation to macrophages.

  2001cited by this paper
• 11b-Hydroxysteroid Dehydrogenase Type 1 Is Induced in Human Monocytes upon Differentiation to Macrophages

  2001cited by this paper
• Improved Lipid and Lipoprotein Profile, Hepatic Insulin Sensitivity, and Glucose Tolerance in 11β-Hydroxysteroid Dehydrogenase Type 1 Null Mice*

  2001cited by this paper
• Induction of 11beta-hydroxysteroid dehydrogenase type 1 but not -2 in human aortic smooth muscle cells by inflammatory stimuli.

  2001cited by this paper
• Type 1 11β-Hydroxysteroid Dehydrogenase Mediates Glucocorticoid Activation and Insulin Release in Pancreatic Islets*

  2000cited by this paper
• How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions.

  2000cited by this paper
• Simvastatin Has Anti-Inflammatory and Antiatherosclerotic Activities Independent of Plasma Cholesterol Lowering

  2000cited by this paper
• PPARalpha agonists reduce 11beta-hydroxysteroid dehydrogenase type 1 in the liver.

  2000cited by this paper
• Enhancing versus suppressive effects of stress hormones on skin immune function.

  1999cited by this paper
• Hypertension in mice lacking 11beta-hydroxysteroid dehydrogenase type 2.

  1999cited by this paper
• Clustering of metabolic factors and coronary heart disease.

  1999cited by this paper
• Syndrome X and mortality: a population-based study. Risk Factor and Life Expectancy Research Group.

  1998cited by this paper
• Localization of 2 11beta-OH steroid dehydrogenase isoforms in aortic endothelial cells.

  1998cited by this paper
• Nongenetic mouse models of non-insulin-dependent diabetes mellitus.

  1998cited by this paper
• Phosphoenolpyruvate Carboxykinase (GTP) Gene Transcription and Hyperglycemia Are Regulated by Glucocorticoids in Genetically Obesedb/db Transgenic Mice*

  1997cited by this paper
• 11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress.

  1997cited by this paper
• Does central obesity reflect "Cushing's disease of the omentum"?

  1997cited by this paper
• 11 b-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress

  1997cited by this paper
• Heterogeneity in adipose tissue metabolism: causes, implications and management of regional adiposity.

  1995cited by this paper
• Cloning and tissue distribution of the human 11 beta-hydroxysteroid dehydrogenase type 2 enzyme.

  1994cited by this paper
• Cloning and tissue distribution of the human 11 beta-hydroxysteroid dehydrogenase type 2 enzyme.

  1994cited by this paper
• Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E.

  1992cited by this paper
• Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells.

  1992cited by this paper
• Roles of insulin resistance and beta-cell dysfunction in dexamethasone-induced diabetes.

  1992cited by this paper
• Insulin secretion, insulin sensitivity and glucose‐mediated glucose disposal in Cushing's disease: a minimal model analysis

  1991cited by this paper
• Cloning and expression of rat cDNA encoding corticosteroid 11 beta-dehydrogenase.

  1989cited by this paper
• The Prospective Cardiovascular Münster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease.

  1988cited by this paper
• Adrenalectomy and Steroid Treatment in Obese (ob/ob) and Diabetic (db/db) Mice

  1987cited by this paper
• Effect of adrenalectomy on the pancreas of db/db mice.

  1986cited by this paper
• Insulin resistance in Cushing's syndrome.

  1983cited by this paper
• 0013-7227/02/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 87(6):2701–2705 Printed in U.S.A. Copyright © 2002 by The Endocrine Society Expression of the mRNA Coding for 11�-Hydroxysteroid Dehydrogenase Type 1 in Adipose Tissue from Obese Pat

  year unknowncited by this paper

• Expression of IMD-CBM peptide induces the autophagic degradation of CAV1 (caveolin 1) to inhibit LDL transcytosis and retard diabetic atherosclerosis.

  2026cites this paper
• DSOK‐0011 Potentially Regulates Circadian Misalignment and Affects Gut Microbiota Composition in Activity‐Based Anorexia Model

  2025cites this paper
• Structure-based design, synthesis, and evaluation of tetrahydrotriazolothiazepine derivatives as novel 11β-hydroxysteroid dehydrogenase type 1 inhibitors.

  2025cites this paper
• Uncovering the Bidirectional Molecular Pathway: How Shugan Wendan Decoction Treats Concurrent Depression and Atherosclerosis.

  2025cites this paper
• Brain 11β-Hydroxysteroid Dehydrogenase Type 1 Occupancy by Xanamem™ Assessed by PET in Alzheimer’s Disease and Cognitively Normal Individuals

  2024cites this paper
• β-adrenergic stimulation-induced PVAT dysfunction in male sex: a role for 11β-hydroxysteroid dehydrogenase-1.

  2024cites this paper
• Unlocking the genetic tapestry of autoimmune diseases: Unveiling common genes across multiple conditions

  2024cites this paper
• Effects of the Pituitary-targeted Gland Axes on Hepatic Lipid Homeostasis in Endocrine-associated Fatty Liver Disease-A Concept Worth Revisiting

  2024cites this paper
• Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease

  2024cites this paper
• Inhibition of the glucocorticoid-activating enzyme 11β-hydroxysteroid dehydrogenase type 1 drives concurrent 11-oxygenated androgen excess

  2023cites this paper
• Contribution of local regeneration of glucocorticoids to tissue steroid pools

  2023cites this paper
• Assessment of steroid enzymes action in children and adolescents with obesity.

  2023cites this paper
• Employing Molecular Docking Calculations for the Design of Alkyl (2-Alcoxy-2-Hydroxypropanoyl)-L-Tryptophanate Derivatives as Potential Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1)

  2023cites this paper
• Discovery of 1'-(1-phenylcyclopropane-carbonyl)-3H-spiro[isobenzofuran-1,3'-pyrrolidin]-3-one as a novel steroid mimetic scaffold for the potent and tissue-specific inhibition of 11β-HSD1 using a scaffold-hopping approach.

  2022cites this paper
• 11β-Hydroxysteroid Dehydrogenase Type 1 as a Potential Treatment Target in Cardiovascular Diseases

  2022cites this paper
• Non-invasive in vivo assessment of 11β-hydroxysteroid dehydrogenase type 1 activity by 19F-Magnetic Resonance Spectroscopy

  2022cites this paper
• 11β-HSD as a New Target in Pharmacotherapy of Metabolic Diseases

  2022cites this paper
• Calcium-Deficiency during Pregnancy Affects Insulin Resistance in Offspring

  2021cites this paper
• Pathophysiology of NASH in endocrine diseases

  2021cites this paper
• Glucocorticoids: Fuelling the Fire of Atherosclerosis or Therapeutic Extinguishers?

  2021cites this paper
• Hepatocyte ATF3 protects against atherosclerosis by regulating HDL and bile acid metabolism

  2021cites this paper
• HSD11B1 is upregulated synergistically by IFNγ and TNFα and mediates TSG-6 expression in human UC-MSCs

  2020cites this paper
• Diets with low n-6:n-3 PUFA ratio protects rats from fructose-induced dyslipidemia and associated hepatic changes: Comparison between 18:3 n-3 and long-chain n-3 PUFA.

  2020cites this paper
• Hepatocyte ATF3 protects against atherosclerosis by regulating HDL and bile acid metabolism

  2020cites this paper
• 11βHSD1 Inhibition with AZD4017 Improves Lipid Profiles and Lean Muscle Mass in Idiopathic Intracranial Hypertension

  2020cites this paper
• Potential of single bulb garlic (Allium sativum) active compound as an 11β-HSD1 inhibitor in obesity through in silico method

  2020cites this paper
• Long‐term magnesium supplementation improves glucocorticoid metabolism: A post‐hoc analysis of an intervention trial

  2020cites this paper
• 11β-hydroxysteroid dehydrogenase type 1 inhibitor use in human disease- a systematic review and narrative synthesis.

  2020cites this paper
• Investigating glucocorticoids as mediators of increased bone marrow adiposity and bone loss

  2020cites this paper
• Glucocorticoids are active players and therapeutic targets in atherosclerotic cardiovascular disease.

  2020cites this paper
• An ANGPTL4–ceramide–protein kinase Cζ axis mediates chronic glucocorticoid exposure–induced hepatic steatosis and hypertriglyceridemia in mice

  2019cites this paper
• Glucocorticoid Metabolism and Activation

  2019cites this paper
• mediates chronic and in

  2019cites this paper
• Targeted Endocrine Therapy: Design, Synthesis, and Proof-of-Principle of 17β-Hydroxysteroid Dehydrogenase Type 2 Inhibitors in Bone Fracture Healing.

  2019cites this paper
• Expression and activity of the cortisol-activating enzyme 11β-hydroxysteroid dehydrogenase type 1 is tissue and species-specific.

  2019cites this paper
• 11β Hydroxysteroid dehydrogenase – 1 activity in type 2 diabetes mellitus: a comparative study

  2019cites this paper
• Maternal high-fructose intake increases circulating corticosterone levels via decreased adrenal corticosterone clearance in adult offspring.

  2019cites this paper
• Early weaning leads to specific glucocorticoid signalling in fat depots of adult rats

  2019cites this paper
• The Glucocorticoid Receptor in Cardiovascular Health and Disease

  2019cites this paper
• 11β-Hydroxysteroid dehydrogenases control access of 7β,27-dihydroxycholesterol to retinoid-related orphan receptor γ

  2019cites this paper
• Enzymatic interconversion of the oxysterols 7β,25-dihydroxycholesterol and 7-keto,25-hydroxycholesterol by 11β-hydroxysteroid dehydrogenase type 1 and 2.

  2019cites this paper
• Atheroprotective Effects and Molecular Targets of Tanshinones Derived From Herbal Medicine Danshen

  2018cites this paper
• A novel highly potent and selective 11&bgr;‐hydroxysteroid dehydrogenase type 1 inhibitor, INU‐101

  2018cites this paper
• 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor Development by Lentiviral Screening Based on Computational Modeling

  2018cites this paper
• Edinburgh Research Explorer The 11-beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitor INCB13739 Improves Hyperglycemia in Patients With Type 2 Diabetes Inadequately Controlled by Metformin Monotherapy

  2018cites this paper
• 11β-HSD1 in Human Fetal Membranes as a Potential Therapeutic Target for Preterm Birth.

  2018cites this paper
• Genetic variants of the 11 beta-hydroxysteroid dehydrogenase type 1 gene influence metabolic syndrome

  2018cites this paper
• 11β-hydroxysteroid dehydrogenase type 1 inhibitor attenuates high-fat diet induced cardiomyopathy.

  2018cites this paper
• Fimasartan Ameliorates Nonalcoholic Fatty Liver Disease through PPARδ Regulation in Hyperlipidemic and Hypertensive Conditions

  2017cites this paper
• Cellular regulation of cortisol in vivo by 11-beta hydroxysteroid dehydrogenase type 1

  2017cites this paper
• Thiazolopyridines Improve Adipocyte Function by Inhibiting 11 Beta-HSD1 Oxoreductase Activity

  2017cites this paper
• Impaired Vascular Function in Sarcoidosis Patients.

  2017cites this paper
• Dysregulation of glucocorticoid metabolism in murine obesity

  2017cites this paper
• The 11beta - Hydroxysteroid Dehydrogenase Enzyme and Obesity

  2017cites this paper
• Explorer The anti-inflammatory and immunosuppressive effects of glucocorticoids , recent developments and mechanistic insights

  2017cites this paper
• Discovery of Clinical Candidate 2-((2S,6S)-2-Phenyl-6-hydroxyadamantan-2-yl)-1-(3'-hydroxyazetidin-1-yl)ethanone [BMS-816336], an Orally Active Novel Selective 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor.

  2017cites this paper
• Inflammation regulates 11&bgr;‐hydroxysteroid dehydrogenase type 1 differentially in specific compartments of the gut mucosal immune system

  2017cites this paper
• Cortisol Metabolism as a Regulator of the Tissue-Specific Glucocorticoid Action

  2017cites this paper
• Inhibition or deletion of 11β-HSD1 does not increase angiogenesis in ischemic retinopathy.

  2017cites this paper
• Virtual screening applications in short-chain dehydrogenase/reductase research.

  2017cites this paper
• Calcium-Deficient Diets in Pregnancy and Nursing: Epigenetic Change in Three Generations of Offspring

  2017cites this paper
• The cortisol-activating enzyme 11β-hydroxysteroid dehydrogenase type 1 in skeletal muscle in the pathogenesis of the metabolic syndrome.

  2017cites this paper
• 11β-HSD1 inhibition ameliorates diabetes-induced cardiomyocyte hypertrophy and cardiac fibrosis through modulation of EGFR activity

  2017cites this paper
• Discontinued drug therapies to treat diabetes in 2015

  2017cites this paper
• Increased Expression of 11β-Hydroxysteroid Dehydrogenase Type 1 in Experimental Periodontitis Induced by Lipopolysaccharide from Porphyromonas gingivalis

  2017cites this paper
• Impact of Adrenal Steroids on Regulation of Adipose Tissue.

  2017cites this paper
• 11&bgr;‐Hydroxysteroid Dehydrogenase Type 1 in Obese Subjects With Type 2 Diabetes Mellitus

  2017cites this paper
• Nouveaux dérivés d'aza-tétracyclo

  2017cites this paper
• The Hypothalamic-Pituitary-Adrenal Axis in Health and Disease

  2017cites this paper
• Asthma is associated with atherosclerotic artery changes

  2017cites this paper
• Synthesis and evaluation of colletoic acid core derivatives.

  2016cites this paper
• The increased ratio of 11β-hydroxysteroid dehydrogenase type 1 versus 11β-hydroxysteroid dehydrogenase type 2 in chronic periodontitis irrespective of obesity

  2016cites this paper
• The expression of 11β-hydroxysteroid dehydrogenase type 1 is increased in experimental periodontitis in rats

  2016cites this paper
• Dérivés aza-tétra-cycliques

  2016cites this paper
• MECHANISMS IN ENDOCRINOLOGY: Tissue-specific activation of cortisol in Cushing's syndrome.

  2016cites this paper
• Comparison of gene expression profiles between human and mouse monocyte

  2016cites this paper
• Exacerbated hepatic inflammatory response to diet-induced non-alcoholic fatty liver disease in 1 male 11β-HSD1 knockout mice 2

  2016cites this paper
• Male 11β-HSD1 Knockout Mice Fed Trans-Fats and Fructose Are Not Protected From Metabolic Syndrome or Nonalcoholic Fatty Liver Disease

  2016cites this paper
• Altering adipose tissue responses to glucocorticoids through genetic manipulation of the 11B-HSD1 gene

  2016cites this paper
• Recent advances in the role of cortisol and metabolic syndrome in age-related degenerative diseases

  2016cites this paper
• University of Birmingham Male 11β-HSD1 knockout mice fed trans-fats and fructose are not protected from metabolic syndrome or non-alcoholic fatty liver disease

  2016cites this paper
• Studies on Therapeutic Targets for Type 2 Diabetes Using Small-molecule Ligands

  2016cites this paper
• Getting to the heart of intracellular glucocorticoid regeneration: 11β-HSD1 in the myocardium

  2016cites this paper
• Characterization of the psycho-neuro-immunological state in patients with coronary artery disease

  2016cites this paper
• Pharmacophore Models and Pharmacophore-Based Virtual Screening: Concepts and Applications Exemplified on Hydroxysteroid Dehydrogenases

  2015cites this paper
• 11β-HSD1 modulates LPS-induced innate immune responses in adipocytes by altering expression of PTEN.

  2015cites this paper
• 11β-Hydroxysteroid dehydrogenase 1: Regeneration of active glucocorticoids is only part of the story.

  2015cites this paper
• Synthesis and biological evaluation of picolinamides as potent inhibitors of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1).

  2015cites this paper
• A novel highly potent and selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, UI-1499.

  2015cites this paper
• Targeting Tissue-Specific Enzymatic Cascades of Local Angiotensin System in Human Atheroma

  2015cites this paper
• Glycogen storage disease type Ia (GSDIa) but not Glycogen storage disease type Ib (GSDIb) is associated to an increased risk of metabolic syndrome: possible role of microsomal glucose 6-phosphate accumulation

  2015cites this paper
• Pistacia lentiscus Oleoresin: Virtual Screening and Identification of Masticadienonic and Isomasticadienonic Acids as Inhibitors of 11β-Hydroxysteroid Dehydrogenase 1

  2015cites this paper
• Pharmacological characterization of the selective 11β-hydroxysteroid dehydrogenase 1 inhibitor, BI 135585, a clinical candidate for the treatment of type 2 diabetes.

  2015cites this paper
• A potent and selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, SKI2852, ameliorates metabolic syndrome in diabetic mice models.

  2015cites this paper
• The Dehydrogenase Hypothesis.

  2015cites this paper
• vasculatureproinflammatory gene expression in the -HSD1 inhibition reduces atherosclerosis in mice by

  2015cites this paper
• Continuous inhibition of 11β‐hydroxysteroid dehydrogenase type I in adipose tissue leads to tachyphylaxis in humans and rats but not in mice

  2015influential citation
• New perspectives on the development of antiobesity drugs.

  2015cites this paper
• Mechanisms of glucocorticoid-induced insulin resistance: focus on adipose tissue function and lipid metabolism.

  2014cites this paper
• QSAR Study of Arylsulfonylpiperazine Inhibitors of 11β-HSD1 by GA-MLR, GA-PLS and GA-ANN

  2014cites this paper